Weiming Yao

Weiming Yao

Auto-generated profile, based on publicly available information

Weiming Yao

Department of Infectious Diseases National Clinical Research Center for Infectious Disease Shenzhen Third People's Hospital The Second Affiliated Hospital School of Medicine Southern University of Science and Technology Shenzhen Guangdong China

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2018 in Antiviral Research
Verified
Journal Article
Closed access
YLYan Liu
Yan Liu
WYWeiming Yao
Weiming Yao
LSLanlan Si
Lanlan Si
JHJun Hou
Jun Hou
JWJiabo Wang
Jiabo Wang
DXDongping Xu
Dongping Xu

27 July 2022 in Emerging Microbes & Infections
Verified
Journal Article
Open access
WCWalton Chan
Walton Chan
Franklin Wang Ngai CHOWFranklin Wang Ngai CHOW
Franklin Wang Ngai CHOW
CTChi-Ching Tsang
Chi-Ching Tsang
XLXueyan Liu
Xueyan Liu
WYWeiming Yao
Weiming Yao
Patrick WooPatrick Woo
Patrick Woo
Drug resistance derived from extracellular vesicles (EVs) is an increasingly important research area but has seldom been described regarding fungal pathogens. Here, we characterized EVs derived from a triazole-resistant but amphotericin B-susceptible strain of Candida auris. Nano- to microgram concentrations of C. auris EVs prepared from both broth and solid agar cultures could robustly increase the yeast’s survival against both pure and clinical amphotericin B formulations in a dose-dependent manner, resulting in up to 16-fold changes of minimum inhibitory concentration. Meanwhile, this effect was not observed upon addition of these EVs to C. albicans, nor upon addition of C. albicans EVs to C. auris. No change in susceptibilities was observed upon EV treatment for fluconazole, voriconazole, micafungin, and flucytosine. Mass spectrometry indicated the presence of immunogenic-/drug resistance-implicated proteins in C. auris EVs, including alcohol dehydrogenase 1 as well as C. albicans Mp65-like and Xog1-like proteins in high quantities. Based on these observations, we propose a potential species-specific role for EVs in amphotericin B resistance in C. auris. These observations may provide critical insights into treatment of multidrug-resistant C. auris.

5 July 2015 in Gastroenterology Research and Practice
Verified
Journal Article
Open access
PDF file
ZYZhijian Yu
Zhijian Yu
LHLi Hui
Li Hui
YWYao Weiming
Yao Weiming
LZLin Zhanzhou
Lin Zhanzhou
CZChen Zhong
Chen Zhong
QDQiwen Deng
Qiwen Deng
This study described an index of aspartate aminotransferase-to-platelet ratio index (APRI) to assess hepatic fibrosis with limited expense and widespread availability compared to the liver biopsy in adolescent patients with CHB.

10 March 2024 in iLABMED
Verified
Journal Article
Open access
PDF file
CCChuming Chen
Chuming Chen
WYWeiming Yao
Weiming Yao
SHSiran Huang
Siran Huang
LPLing Peng
Ling Peng
SFShiyan Feng
Shiyan Feng
FWFuxiang Wang
Fuxiang Wang
Since the first reported case of monkeypox in the UK in May 2022, there has been an upward trend in monkeypox cases and a global outbreak. However, reports of severe cases are relatively limited. In this study, we report a case of severe monkeypox in a patient with HIV. The patient presented with skin lesions that started on his face and around the penis and persisted for several months. Throughout the course of the disease, he received systematic symptomatic supportive treatment, topical remedies, and special care for the rash. He also underwent cidofovir antiviral therapy and smallpox‐vaccinated healthy population‐derived plasma therapy in succession, with the condition ultimately showing improvement after plasma treatment. After more than 3 months of hospitalization, he fully recovered. To the best of our knowledge, this is the first reported use of smallpox‐vaccinated healthy population‐derived plasma in the treatment of severe monkeypox cases.